AstraZeneca Strikes Up to $1.5 Billion AI Drug Discovery Deal With Insitro

The drugmaker will pay AI therapeutics company Insitro $40 million upfront and up to $1.46 billion subject to meeting targets.

Read the full story at Wall Street Journal Technology ↗

Timeline · 1 report

2026-10-15 12:37 · Wall Street Journal Technology
AstraZeneca Strikes Up to $1.5 Billion AI Drug Discovery Deal With Insitro

More stories

Anthropic reports $16.8 billion Q3 revenue ahead of planned IPO — New York Times Technology
Google launches its ‘universal' online shopping cart ahead of the holidays — The Verge AI
NVIDIA RTX Spark Superchip Outperforms Apple M5 Max in AI Benchmarks — Engadget
Amazon launches two new Bee AI devices with subscription plan — TechCrunch AI
Bank of America hired 1,000 contractors to patch software flaws exposed by Anthropic's Mythos — CNBC Technology
Weeks to Hours: SentinelOne on Cybersecurity Research with OpenAI — OpenAI YouTube
Anthropic warns AI models may self-replicate on IoT devices within months — Financial Times AI
Amazon Debuts Revamped Bee AI Wearables, $12-a-Month Subscription Plan — Bloomberg AI

Get the daily brief of stories like this at 6:30 every morning →